Westwood Holdings Group Inc. Acquires 11,261 Shares of Teleflex Incorporated $TFX

Westwood Holdings Group Inc. boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 10.2% in the second quarter, HoldingsChannel reports. The fund owned 121,534 shares of the medical technology company’s stock after acquiring an additional 11,261 shares during the period. Westwood Holdings Group Inc.’s holdings in Teleflex were worth $14,385,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares in the last quarter. Brooklyn Investment Group increased its position in Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after buying an additional 150 shares in the last quarter. True Wealth Design LLC raised its stake in Teleflex by 10,333.3% during the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after buying an additional 310 shares during the last quarter. Parallel Advisors LLC raised its stake in Teleflex by 43.1% during the second quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock valued at $54,000 after buying an additional 137 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of Teleflex by 30.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company’s stock worth $77,000 after acquiring an additional 129 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Truist Financial reduced their price target on Teleflex from $128.00 to $120.00 and set a “hold” rating for the company in a report on Monday, November 10th. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. Royal Bank Of Canada cut their price target on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a report on Friday, November 7th. Finally, Wells Fargo & Company raised their price target on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $138.14.

Teleflex Stock Performance

Shares of NYSE TFX opened at $126.69 on Monday. The firm’s 50-day moving average price is $120.22 and its 200-day moving average price is $120.92. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The company has a market cap of $5.60 billion, a PE ratio of -17.24, a PEG ratio of 1.51 and a beta of 0.95. Teleflex Incorporated has a 52-week low of $102.58 and a 52-week high of $185.94.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The firm’s quarterly revenue was up 19.4% on a year-over-year basis. During the same period in the previous year, the company earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is -18.50%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.